Appropriate Dose Modification in Induction Therapy Is Essential for the Treatment of Infants with Acute Myeloid Leukemia; A Report From the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).
Author:
Daisuke Tomizawa,Akio Tawa,Tomoyuki Watanabe,Akiko Moriya Saito,Kazuko Kudo,Takashi Taga,Shotaro Iwamoto,Akira Shimada,Kiminori Terui,Hiroshi Moritake,Akitoshi Kinoshita,Hiroyuki Takahashi,Hideki Nakayama,Katsuyoshi Koh,Hisato Kigasawa et al.
Copyright © 2012 American Society of Hematology